Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Anesthetizing walruses is difficult and risky due to their size and sudden health changes.

Activating δ-opioid receptors can help hair grow.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

A(1-7) treatment reduces symptoms of lupus in mice.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Losartan can cause temporary loss of taste.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.